When Global Order Begins To Fracture Authored by Milan Adams via Preppgroup blog, There are moments in history when the world changes with noise — sirens, speeches, falling statues. And then there are moments when it changes so quietly that almost nobody realizes it is happening. We are living through the second kind. No formal announcement marked the transition. No historic summit collapsed on li...
When Global Order Begins To Fracture Authored by Milan Adams via Preppgroup blog, There are moments in history when the world changes with noise — sirens, speeches, falling statues. And then there are moments when it changes so quietly that almost nobody realizes it is happening. We are living through the second kind. No formal announcement marked the transition. No historic summit collapsed on live television. No leader stepped forward to say: the old rules no longer apply . And yet, somewhere between the war in Ukraine , the tightening strategic alignment between Russia and China , and the silent expiration of the New START in February 2026, the global system that kept great-power rivalry inside predictable boundaries began to dissolve. Not explode. Dissolve. For decades, the world’s stability did not come from trust. It came from limits. From inspection regimes. From numbers written into treaties. From the strange comfort of knowing exactly how dangerous your adversary was allowed to be. Military planners in Moscow and Washington worked with ceilings. Diplomats worked with verification schedules. Leaders worked with red lines that had legal meaning. Those ceilings are now gone, and most of the public has not noticed because nothing dramatic happened the day they disappeared. The Strategic Triangle That No Longer Moves For years, American strategists believed the triangle between Washington, Moscow, and Beijing could be manipulated. If relations with one deteriorated, the other could be courted. It was the logic behind the Cold War opening to China and the repeated attempts to “reset” relations with Moscow. There was a quiet confidence that Russia, culturally tied to Europe and historically wary of China, would never fully lean toward Beijing. That confidence now looks misplaced. Today, the United States faces not two separate rivals but two powers whose interests increasingly overlap: Both view American sanctions as a weapon of political coercion Both seek to dil...
Earnings Call Insights: Profound Medical Corp. (prn:ca) Q1 2026 Management View Rashed Dewan (Chief Financial Officer) said the company “recorded revenue of $5.3 million” in Q1 2026, including “$2.5 million from recurring revenue and $2.9 million from onetime sale of capital equipment,” and reported “gross margin in Q1 2026 was 72%.” Rashed Dewan (Chief Financial Officer) reported operating levera...
Earnings Call Insights: Profound Medical Corp. (prn:ca) Q1 2026 Management View Rashed Dewan (Chief Financial Officer) said the company “recorded revenue of $5.3 million” in Q1 2026, including “$2.5 million from recurring revenue and $2.9 million from onetime sale of capital equipment,” and reported “gross margin in Q1 2026 was 72%.” Rashed Dewan (Chief Financial Officer) reported operating leverage and liquidity, saying “total operating expenses in the 2026 first quarter were $11.8 million,” and “as of March 31, 2026, Profound had cash of $50.3 million.” Dr. Mathieu Burtnyk (President) highlighted the CAPTAIN readout, stating “the CAPTAIN trial demonstrated that TULSA delivered statistically superior quality of life outcomes compared to radical prostatectomy,” including “statistically higher preservation of the composite endpoint of urinary continence and erectile function at 6 months.” Dr. Arun Menawat (Chairman of the Board & CEO) emphasized utilization mix and positioning, saying “about 91% of TULSA patient prostates are treated either as whole gland or more than 50% of prostate ablations,” and framed TULSA as mainstream-capable: “only TULSA has the true potential of becoming a mainstream treatment modality.” Dr. Menawat (Chairman of the Board & CEO) detailed infrastructure and growth indicators, announcing a “new TULSA index table” built from “20 sites” to show “the rate of growth of same-store sales,” and disclosed “the TULSA-PRO installed base was 80 at the end of Q1 2026, and we shipped an additional 6 systems during the first quarter that have yet to be installed.” Dr. Menawat (Chairman of the Board & CEO) tied growth to interventional MRI and partners, saying “the Siemens Free series… is now available and COOK Medical is partnering with them to provide a turnkey iMRI solution,” and added, “we anticipate that if all goes well, TULSA will get FDA clearance for integration with the new interventional MR by year-end.” Outlook Dr. Arun Menawat (Chairman of the ...